Bio-Techne to Present at Investor Conferences
Bio-Techne Corporation (NASDAQ: TECH) has announced its participation in three major upcoming investor conferences in June 2025. The company will present at the William Blair 45th Annual Growth Stock Conference on June 3 at 2:40 PM CDT, the Jefferies Global Healthcare Conference on June 4 at 3:45 PM EDT, and the Goldman Sachs 46th Annual Global Healthcare Conference on June 10 at 10:40 AM EDT. Investors can access live webcasts of all presentations through Bio-Techne's Investor Relations website.
Bio-Techne Corporation (NASDAQ: TECH) ha annunciato la sua partecipazione a tre importanti conferenze per investitori previste per giugno 2025. L'azienda presenterà al William Blair 45th Annual Growth Stock Conference il 3 giugno alle 14:40 CDT, al Jefferies Global Healthcare Conference il 4 giugno alle 15:45 EDT e al Goldman Sachs 46th Annual Global Healthcare Conference il 10 giugno alle 10:40 EDT. Gli investitori potranno seguire tutte le presentazioni in diretta streaming attraverso il sito web delle Relazioni con gli Investitori di Bio-Techne.
Bio-Techne Corporation (NASDAQ: TECH) ha anunciado su participación en tres importantes conferencias para inversores que se celebrarán en junio de 2025. La compañía presentará en la William Blair 45th Annual Growth Stock Conference el 3 de junio a las 2:40 PM CDT, en la Jefferies Global Healthcare Conference el 4 de junio a las 3:45 PM EDT y en la Goldman Sachs 46th Annual Global Healthcare Conference el 10 de junio a las 10:40 AM EDT. Los inversores podrán acceder a las transmisiones en vivo de todas las presentaciones a través del sitio web de Relaciones con Inversores de Bio-Techne.
Bio-Techne Corporation (NASDAQ: TECH)는 2025년 6월에 열리는 세 개의 주요 투자자 컨퍼런스에 참여할 것이라고 발표했습니다. 회사는 6월 3일 오후 2시 40분 CDT에 열리는 William Blair 45th Annual Growth Stock Conference, 6월 4일 오후 3시 45분 EDT에 열리는 Jefferies Global Healthcare Conference, 그리고 6월 10일 오전 10시 40분 EDT에 열리는 Goldman Sachs 46th Annual Global Healthcare Conference에서 발표할 예정입니다. 투자자들은 Bio-Techne의 투자자 관계 웹사이트를 통해 모든 발표의 실시간 웹캐스트를 시청할 수 있습니다.
Bio-Techne Corporation (NASDAQ : TECH) a annoncé sa participation à trois grandes conférences pour investisseurs prévues en juin 2025. La société présentera lors de la William Blair 45th Annual Growth Stock Conference le 3 juin à 14h40 CDT, lors de la Jefferies Global Healthcare Conference le 4 juin à 15h45 EDT, et lors de la Goldman Sachs 46th Annual Global Healthcare Conference le 10 juin à 10h40 EDT. Les investisseurs pourront accéder aux webcasts en direct de toutes les présentations via le site web des Relations Investisseurs de Bio-Techne.
Bio-Techne Corporation (NASDAQ: TECH) hat seine Teilnahme an drei großen Investorenkonferenzen im Juni 2025 angekündigt. Das Unternehmen wird auf der William Blair 45th Annual Growth Stock Conference am 3. Juni um 14:40 Uhr CDT, der Jefferies Global Healthcare Conference am 4. Juni um 15:45 Uhr EDT und der Goldman Sachs 46th Annual Global Healthcare Conference am 10. Juni um 10:40 Uhr EDT präsentieren. Investoren können alle Präsentationen live über die Investor-Relations-Website von Bio-Techne verfolgen.
- None.
- None.
William Blair 45th Annual Growth Stock Conference
June 3, 2025
2:40 PM CDT
Jefferies Global Healthcare Conference
June 4, 2025
3:45 PM EDT
Goldman Sachs 46th Annual Global Healthcare Conference
June 10, 2025
10:40 AM EDT
A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately
Contact: David Clair, Vice President, Investor Relations & Corporate Development
david.clair@bio-techne.com
612-656-4416
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-investor-conferences-302467190.html
SOURCE Bio-Techne Corporation